Bulletin
Investor Alert

New York Markets Open in:

Market Pulse Archives

Jan. 26, 2021, 12:39 p.m. EST

J&J CEO: Expect Phase 3 results for its COVID-19 vaccine candidate early next week

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Johnson & Johnson (JNJ)
  • X
    BioNTech SE ADR (BNTX)
  • X
    Pfizer Inc. (PFE)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.10% expects to share details from the Phase 3 clinical trial for its COVID-19 vaccine candidate "early next week," according to remarks made by CEO Alex Gorsky on Tuesday during an earnings call. J&J's stock was up 3.0% in trading on Tuesday afternoon. The company's experimental COVID-19 adenovirus-based vaccine is currently being tested in late-stage clinical trials, and results are being closely watched for several reasons, including that it's a single-dose vaccine and there are ongoing supply issues for doses of the BioNTech SE /zigman2/quotes/214419716/composite BNTX -1.61% /Pfizer Inc. /zigman2/quotes/202877789/composite PFE +0.21% and Moderna Inc. /zigman2/quotes/205619834/composite MRNA +2.48% vaccines in the U.S. (Both of the currently authorized coronavirus vaccines in the U.S. require two doses.) "We're certainly hopeful that you're going to see a durable and a sustainable and patent response, particularly from our [adenovirus-based] vector approach," Gorsky told investors, according to a FactSet transcript of the call. J&J's stock is up 15.3% over the past 12 months, while the S&P 500 /zigman2/quotes/210599714/realtime SPX -2.45% has gained 17.0%.

/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 162.76
+0.17 +0.10%
Volume: 9.72M
Feb. 25, 2021 4:00p
P/E Ratio
29.52
Dividend Yield
2.48%
Market Cap
$427.40 billion
Rev. per Employee
$613,918
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 112.33
-1.84 -1.61%
Volume: 1.13M
Feb. 25, 2021 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$27.49 billion
Rev. per Employee
$92,777
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 33.82
+0.07 +0.21%
Volume: 37.51M
Feb. 25, 2021 4:03p
P/E Ratio
19.83
Dividend Yield
4.61%
Market Cap
$187.60 billion
Rev. per Employee
N/A
loading...
/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 148.38
+3.59 +2.48%
Volume: 15.17M
Feb. 25, 2021 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$57.29 billion
Rev. per Employee
$72,541
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,829.34
-96.09 -2.45%
Volume: 2.92B
Feb. 25, 2021 5:19p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.